Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Sep 24;9(9):CD002150.
doi: 10.1002/14651858.CD002150.pub2.

Antibiotics for treating scrub typhus

Iman El Sayed  1 , Qin Liu, Ian Wee, Paul Hine
Affiliations
Meta-Analysis

Antibiotics for treating scrub typhus

Iman El Sayed et al. Cochrane Database Syst Rev. .

Abstract

Background: Scrub typhus, an important cause of acute fever in Asia, is caused by Orientia tsutsugamushi, an obligate intracellular bacterium. Antibiotics currently used to treat scrub typhus include tetracyclines, chloramphenicol, macrolides, and rifampicin.

Objectives: To assess and compare the effects of different antibiotic regimens for treatment of scrub typhus.

Search methods: We searched the following databases up to 8 January 2018: the Cochrane Infectious Diseases Group specialized trials register; CENTRAL, in the Cochrane Library (2018, Issue 1); MEDLINE; Embase; LILACS; and the metaRegister of Controlled Trials (mRCT). We checked references and contacted study authors for additional data. We applied no language or date restrictions.

Selection criteria: Randomized controlled trials (RCTs) or quasi-RCTs comparing antibiotic regimens in people with the diagnosis of scrub typhus based on clinical symptoms and compatible laboratory tests (excluding the Weil-Felix test).

Data collection and analysis: For this update, two review authors re-extracted all data and assessed the certainty of evidence. We meta-analysed data to calculate risk ratios (RRs) for dichotomous outcomes when appropriate, and elsewhere tabulated data to facilitate narrative analysis.

Main results: We included six RCTs and one quasi-RCT with 548 participants; they took place in the Asia-Pacific region: Korea (three trials), Malaysia (one trial), and Thailand (three trials). Only one trial included children younger than 15 years (N = 57). We judged five trials to be at high risk of performance and detection bias owing to inadequate blinding. Trials were heterogenous in terms of dosing of interventions and outcome measures. Across trials, treatment failure rates were low.Two trials compared doxycycline to tetracycline. For treatment failure, the difference between doxycycline and tetracycline is uncertain (very low-certainty evidence). Doxycycline compared to tetracycline may make little or no difference in resolution of fever within 48 hours (risk ratio (RR) 1.14, 95% confidence interval (CI) 0.90 to 1.44, 55 participants; one trial; low-certainty evidence) and in time to defervescence (116 participants; one trial; low-certainty evidence). We were unable to extract data for other outcomes.Three trials compared doxycycline versus macrolides. For most outcomes, including treatment failure, resolution of fever within 48 hours, time to defervescence, and serious adverse events, we are uncertain whether study results show a difference between doxycycline and macrolides (very low-certainty evidence). Macrolides compared to doxycycline may make little or no difference in the proportion of patients with resolution of fever within five days (RR 1.05, 95% CI 0.99 to 1.10; 185 participants; two trials; low-certainty evidence). Another trial compared azithromycin versus doxycycline or chloramphenicol in children, but we were not able to disaggregate date for the doxycycline/chloramphenicol group.One trial compared doxycycline versus rifampicin. For all outcomes, we are uncertain whether study results show a difference between doxycycline and rifampicin (very low-certainty evidence). Of note, this trial deviated from the protocol after three out of eight patients who had received doxycycline and rifampicin combination therapy experienced treatment failure.Across trials, mild gastrointestinal side effects appeared to be more common with doxycycline than with comparator drugs.

Authors' conclusions: Tetracycline, doxycycline, azithromycin, and rifampicin are effective treatment options for scrub typhus and have resulted in few treatment failures. Chloramphenicol also remains a treatment option, but we could not include this among direct comparisons in this review.Most available evidence is of low or very low certainty. For specific outcomes, some low-certainty evidence suggests there may be little or no difference between tetracycline, doxycycline, and azithromycin as treatment options. Given very low-certainty evidence for rifampicin and the risk of inducing resistance in undiagnosed tuberculosis, clinicians should not regard this as a first-line treatment option. Clinicians could consider rifampicin as a second-line treatment option after exclusion of active tuberculosis.Further research should consist of additional adequately powered trials of doxycycline versus azithromycin or other macrolides, trials of other candidate antibiotics including rifampicin, and trials of treatments for severe scrub typhus. Researchers should standardize diagnostic techniques and reporting of clinical outcomes to allow robust comparisons.

PubMed Disclaimer

Conflict of interest statement

IES has no known conflicts of interest. QL has no known conflicts of interest. IW has no known conflicts of interest. PH has no known conflicts of interest.

Figures

1
1
PRISMA flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Forest plot of comparison: 2 Macrolides versus doxycycline, outcome: 2.3 Resolution of fever within five days.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Brown 1978 {published data only}
    1. Brown GW, Saunders JP, Singh SL, Haxsoll DL, Shirai A. Single dose doxycycline therapy for scrub typhus. Transactions of the Royal Society of Tropical Medicine and Hygiene 1978;72(4):412‐6. - PubMed
Chanta 2015 {published data only}
    1. Chanta C, Phloenchaiwanit P. Randomized controlled trial of azithromycin versus doxycycline or chloramphenicol for treatment of uncomplicated pediatric scrub typhus. Journal of the Medical Association of Thailand 2015;98(8):756‐60. - PubMed
Kim 2004 {published data only}
    1. Kim YS, Yun HJ, Shim SK, Koo SH, Kim SY, Kim S. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clinical Infectious Diseases 2004;39(9):1329‐35. - PubMed
Kim 2007 {published data only}
    1. Kim DM, Yu KD, Lee JH, Kim HK, Lee SH. Controlled trial of a 5‐day course of telithromycin versus doxycycline for treatment of mild to moderate scrub typhus. Antimicrobial Agents and Chemotherapy 2007;51(6):2011‐5. - PMC - PubMed
Phimda 2007 {published data only}
    1. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrobial Agents and Chemotherapy 2007;51(9):3259‐63. - PMC - PubMed
Song 1995 {published data only}
    1. Song JH, Lee C, Chang LW, Choi SW, Choi JE, Kim YS, et al. Short‐course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: a multiple randomized trial. Clinical Infectious Diseases 1995;21(3):506‐10. - PubMed
Watt 2000 {published data only}
    1. Watt G, Kantipong P, Jongsakul K, Watcharapichat P, Phulsuksombati D, Strickman D. Doxycycline and rifampicin for mild scrub typhus infections in northern Thailand: a randomised trial. Lancet 2000;356(9235):1057‐61. - PubMed

References to studies excluded from this review

Chen 2007 {published data only}
    1. Chen SX, Lin XM, Shen HF, Zhang LJ, Sun ZM. Treatment of scrub typhus with macrolide antibiotic. Journal of Tropical Medicine 2007;7:783‐84.
Chen 2008 {published data only}
    1. Chen SX, Shen HF, Zhang LJ, Xu CX, Sun ZM. Effect of antibiotics in the treatment of scrub typhus in South China Sea area. Journal of Preventive Medicine of Chinese People's Liberation Army 2008;26:59.
Feng 2009 {published data only}
    1. Feng X. Treatment of scrub typhus with several antibiotics. Journal of Practical Medicine 2009;25:526.
Li 2004 {published data only}
    1. Li Y. Macrolide antibiotic to cure child scrub typhus. Journal of Pediatric Pharmacy 2004;10:36.
Li 2007 {published data only}
    1. Li RC, Pang L, Lu XH. Effect of antibiotics in the treatment of scrub typhus. Modernizing Medicine's Healthcare 2007;23:1936‐7.
Olson 1980 {published data only}
    1. Olson JG, Bourgeois AL, Fang RCY, Coolbaugh JC, Dennes DT. Prevention of scrub typhus: prophylactic administration of doxycycline in a randomized double blind trial. Journal of Tropical Medicine and Hygiene 1980;29(5):989‐97. - PubMed
Quan 2002 {published data only}
    1. Quan B. The third generation of quinolone therapy for scrub typhus. Journal of Tropical Medicine 2002;2:163‐4.
Sheehy 1973 {published data only}
    1. Sheehy TW, Hazlett D, Turk RE. Scrub typhus. A comparison of chloramphenicol and tetracycline in its treatment. Archives of Internal Medicine 1973;132:77‐80. - PubMed
Twartz 1982 {published data only}
    1. Twartz JC, Selvarju SG, Saunders JP, Huxsoll DL, Groves MG. Doxycycline prophylaxis for human scrub typhus. Journal of Infectious Diseases 1982;146(6):811‐8. - PubMed
Wei 2004 {published data only}
    1. Wei MX, Lin SJ, Yan R, Guo WZ. A comparison of azithromycin versus chloramphenicol for treatment of pediatric scrub typhus. Journal of Applied Clinical Pediatrics 2004;19:66.
Wu 2006 {published data only}
    1. Wu X, Xiao H, Zhu DJ. Therapeutic effect of azithromycin on children with tsutsugamushi disease. Chinese Journal of Pediatrics 2006;24:769‐70.
Yang 2005 {published data only}
    1. Yang YF, Li B, Liu XM, Zhang LP. Effect of roxithromycin in the treatment of scrub typhus. Journal of Pediatric Pharmacy 2005;11:32.
Zhong 1996 {published data only}
    1. Zhong ZY, Zhang WY, Wu YX. Scrub typhus. A comparison of doxycycline and chloramphenicol in its treatment. Journal of Guangdong Medical College 1996;14:354‐5.

References to ongoing studies

ISRCTN47812566 {published data only}
    1. ISRCTN47812566. Oral doxycycline versus oral azithromycin in the treatment of scrub and murine typhus in Laos. isrctn.com/ISRCTN47812566 (date applied 7 December 2005).
NCT00351182 {published data only}
    1. NCT00351182. 5‐day course of telithromycin versus doxycycline for the treatment of mild to moderate scrub typhus. ClinicalTrials.gov/show/NCT00351182 (first posted 12 July 2006).
NCT00568711 {published data only}
    1. NCT00568711. Controlled trial: 5‐day course of rifampin versus doxycycline for the treatment of mild to moderate scrub typhus. clinicaltrials.gov/ct2/show/NCT00568711 (first posted 6 December 2007).
NCT03083197 {unpublished data only}
    1. NCT03083197. Scrub typhus antibiotic resistance trial (START). clinicaltrials.gov/show/NCT03083197 (first posted 17 March 2017).

Additional references

Acestor 2012
    1. Acestor N, Cooksey R, Newton PN, Ménard D, Guerin PJ, Nakagawa J, et al. Mapping the aetiology of non‐malarial febrile illness in Southeast Asia through a systematic review ‐ terra incognita impairing treatment policies. PLoS One 2012;7(9):e44269. - PMC - PubMed
Bonell 2017
    1. Bonell A, Lubell Y, Newton PN, Crump JA, Paris DH. Estimating the burden of scrub typhus: a systematic review. PLoS Neglected Tropical Diseases 2017;11(9):e0005838. - PMC - PubMed
CDC 2017
    1. Centers for Disease Control and Prevention. Scrub typhus. www.cdc.gov/typhus/healthcare‐providers/index.html (accessed 13 March 2018).
Corwin 1999
    1. Corwin A, Soderquist R, Suwanabun N, Sattabongkot J, Martin L, Kelly D, et al. Scrub typhus and military operations in Indochina. Clinical Infectious Diseases 1999;29(4):940‐1. - PubMed
GRADEpro 2015 [Computer program]
    1. GRADEpro GDT. GRADEpro Guideline Development Tool. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.), 2015.
Griffith 2014
    1. Griffith M, Peter JV, Karthik G, Ramakrishna K, Prakash JA, Kalki RC, et al. Profile of organ dysfunction and predictors of mortality in severe scrub typhus infection requiring intensive care admission. Indian Journal of Critical Care Medicine 2014;18(8):497‐502. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Kelly 2017
    1. Kelly D, Fuerst P, Richards A. The historical case for and the future study of antibiotic‐resistant scrub typhus. Tropical Medicine and Infectious Disease 2017;2(4):63. - PMC - PubMed
Koralur 2018
    1. Koralur M, Singh R, Varma M, Shenoy S, Acharya V, Kamath A, et al. Scrub typhus diagnosis on acute specimens using serological and molecular assays ‐ a three‐year prospective study. Diagnostic Microbiology and Infectious Disease 2018;91(2):112‐7. [DOI: 10.1016/j.diagmicrobio.2018.01.018] - DOI - PubMed
Paris 2016
    1. Paris DH, Dumler JS. State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Current Opinion in Infectious Diseases 2016;29(5):433‐9. - PMC - PubMed
Rajapakse 2012
    1. Rajapakse S, Rodrigo C, Fernando D. Scrub typhus: pathophysiology, clinical manifestations and prognosis. Asian Pacific Journal of Tropical Medicine 2012;5(4):261‐4. - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A, editors. Introduction to GRADE HandbookHandbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013. http://gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed 18 April 2018).
Smadel 1950
    1. Smadel JE, Traub R, Frick LP, Dierck FH, Bailey CA. Chloramphenicol (chloromycetin) in the chemoprophylaxis of scrub typhus (Tsutsugamushi disease). American Journal of Hygiene 1950;51:216‐28.
Tantibhedhyangkul 2010
    1. Tantibhedhyangkul W, Angelakis E, Tongyoo N, Newton PN, Moore CE, Phetsouvanh R, et al. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. International Journal of Antimicrobial Agents 2010;35(4):338‐41. - PMC - PubMed
Taylor 2015
    1. Taylor AJ, Paris DH, Newton PN. A systematic review of mortality from untreated scrub typhus (Orientia tsutsugamushi). PLoS Neglected Tropical Diseases 2015;9(8):e0003971. - PMC - PubMed
Thipmontree 2016
    1. Thipmontree W, Tantibhedhyangkul W, Silpasakorn S, Wongsawat E, Waywa D, Suputtamongkol Y. Scrub typhus in Northeastern Thailand: eschar distribution, abnormal electrocardiographic findings, and predictors of fatal outcome. American Journal of Tropical Medicine and Hygiene 2016;95(4):769‐73. - PMC - PubMed
Watt 1996
    1. Watt G, Chouriyagune C, Ruangweerayud T, Watcharapichat P, Phulsuksombati D, Jongasakul K, et al. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet 1996;348:86‐9. - PubMed
Watt 2003
    1. Watt G, Parola P. Scrub typhus and tropical rickettsioses. Current Opinion in Infectious Disease 2003;16(5):429‐36. - PubMed
Wee 2017
    1. Wee I, Lo A, Rodrigo C. Drug treatment of scrub typhus: a systematic review and meta‐analysis of controlled clinical trials. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017;111(8):336‐44. - PubMed

References to other published versions of this review

Liu 2002
    1. Liu Q, Panpanich R. Antibiotics for treating scrub typhus. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD002150] - DOI - PubMed
Panpanich 2000
    1. Panpanich R, Garner P. Antibiotics for treating scrub typhus. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD002150] - DOI - PubMed

MeSH terms

LinkOut - more resources